C‐reactive protein as a regulator of autoimmunity and inflammation
Open Access
- 3 June 2003
- journal article
- editorial
- Published by Wiley in Arthritis & Rheumatism
- Vol. 48 (6) , 1475-1477
- https://doi.org/10.1002/art.11025
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Delayed lupus onset in (NZB × NZW)F1 mice expressing a human C‐reactive protein transgeneArthritis & Rheumatism, 2003
- C-Reactive Protein Mediates Protection from Lipopolysaccharide Through Interactions With FcγRThe Journal of Immunology, 2002
- Platelet‐derived growth factor activates production of reactive oxygen species by NAD(P)H‐oxidase in smooth muscle cells through Gi1,2The FASEB Journal, 2002
- Experimental Allergic Encephalomyelitis Is Inhibited in Transgenic Mice Expressing Human C-Reactive ProteinThe Journal of Immunology, 2002
- Reversal of Proinflammatory Responses by Ligating the Macrophage Fcγ Receptor Type IThe Journal of Experimental Medicine, 1998
- Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemiaProceedings of the National Academy of Sciences, 1997
- Decreased Autoantibody Levels and Enhanced Survival of (NZB × NZW) F1 Mice Treated with C-Reactive ProteinClinical Immunology and Immunopathology, 1994
- Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells.The Journal of Experimental Medicine, 1993
- C-reactive protein (CRP) binding to the Sm-D protein of snRNPS. Identification of a short polypeptide binding regionMolecular Immunology, 1993
- Induction of inflammatory cytokine release from cultured human monocytes by C-reactive proteinCytokine, 1992